UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )


Filed by the Registrant ☒
​
Filed by a party other than the Registrant  ☐

Check the appropriate box:
 ☐
​
Preliminary Proxy Statement
 ☐
​
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐
​
Definitive Proxy Statement
☒
​
Definitive Additional Materials
 ☐
​
Soliciting Material Pursuant to §240.14a-12
Infinity Pharmaceuticals, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):
☒
​
No fee required.
 ☐
​
Fee paid previously with preliminary materials.
 ☐
​
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.




Infinity Pharmaceuticals (NASDAQ:INFI)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024 Infinity Pharmaceuticals 차트를 더 보려면 여기를 클릭.
Infinity Pharmaceuticals (NASDAQ:INFI)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024 Infinity Pharmaceuticals 차트를 더 보려면 여기를 클릭.